The major objective of the present proposal is to develop new therapeutic strategies for the treatment of brain diseases. The aim is to restore, maintain and improve cell, tissue and organ functions within the Central Nervous System (CNS). Emphasis is on two kinds of diseases: brain cancer and neurodegenerative disorders, namely Parkinson ' s and Huntington ' s Disease. The treatment of CNS diseases is very difficult due to the Blood Brain Barrier, hindering most drugs to reach the brain tissue. Thus, target-specific delivery systems are required. Using a multi-disciplinary approach we will develop new pharmaceutical devices releasing highly potent drugs in a controlled manner into the CNS. The whole range of innovation, from advanced research, through technological development up to in vivo evaluation will be covered. With an industrial company in the consortium, also the economic exploitation of the outcoming scientific results is foreseen.
Funding SchemeCSC - Cost-sharing contracts